Aquestive Therapeutics, Inc.
AQST
$6.45
$0.304.80%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 65.69% | -32.64% | -27.88% | 199.71% | 212.61% |
| Total Receivables | 21.86% | 97.80% | 25.47% | -13.30% | 13.26% |
| Inventory | 12.29% | 16.64% | -6.93% | -10.71% | -0.82% |
| Prepaid Expenses | 48.33% | 1.61% | 35.31% | 77.24% | 3.19% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 57.06% | -21.43% | -21.35% | 115.35% | 127.45% |
|
|
|||||
| Total Current Assets | 57.06% | -21.43% | -21.35% | 115.35% | 127.45% |
| Net Property, Plant & Equipment | -5.14% | -6.27% | -6.72% | -7.75% | -10.39% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -100.00% | -100.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -24.37% | -24.30% | -22.19% | -22.34% | -22.44% |
| Total Assets | 48.75% | -20.33% | -21.07% | 76.64% | 84.97% |
|
|
|||||
| Total Accounts Payable | 43.49% | 109.81% | 16.70% | 15.25% | -24.23% |
| Total Accrued Expenses | 13.21% | -5.45% | -26.61% | -7.74% | -8.10% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1,266.47% | 682.25% | 29.75% | 30.10% | -89.80% |
| Total Finance Division Other Current Liabilities | 2.15% | 2.25% | -16.78% | -17.19% | -43.46% |
| Total Other Current Liabilities | 2.15% | 2.25% | -16.78% | -17.19% | -43.46% |
| Total Current Liabilities | 68.78% | 66.64% | 1.33% | 3.04% | -37.02% |
|
|
|||||
| Total Current Liabilities | 68.78% | 66.64% | 1.33% | 3.04% | -37.02% |
| Long-Term Debt | -4.12% | 6.26% | 17.54% | 18.36% | -10.00% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -12.01% | -11.12% | -9.01% | -8.22% | -4.48% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.64% | 2.58% | -6.53% | -6.60% | 5.71% |
| Total Liabilities | 7.91% | 8.63% | -1.60% | -1.42% | -4.31% |
|
|
|||||
| Common Stock & APIC | 36.67% | 9.34% | 10.02% | 42.56% | 44.56% |
| Retained Earnings | -19.93% | -19.44% | -16.34% | -13.83% | -11.32% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 90.95% | -104.60% | -67.85% | 43.51% | 55.87% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 90.95% | -104.60% | -67.85% | 43.51% | 55.87% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 90.95% | -104.60% | -67.85% | 43.51% | 55.87% |
|
|
|||||